Last reviewed · How we verify
Xinnaoning Capsule — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Xinnaoning Capsule (Xinnaoning Capsule) — Beijing Duheng for Drug Evaluation and Research Co., Ltd. (DDER).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Xinnaoning Capsule TARGET | Xinnaoning Capsule | Beijing Duheng for Drug Evaluation and Research Co., Ltd. (DDER) | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Xinnaoning Capsule CI watch — RSS
- Xinnaoning Capsule CI watch — Atom
- Xinnaoning Capsule CI watch — JSON
- Xinnaoning Capsule alone — RSS
Cite this brief
Drug Landscape (2026). Xinnaoning Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/xinnaoning-capsule. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab